NASDAQ:VERU

Veru (VERU) News Today

$1.01

+0.02 (+2.02%)

(As of 10:40 AM ET)

Compare

Today's Range: $0.96
▼
$1.02
50-Day Range: $0.99
▼
$1.49
52-Week Range: $0.93
▼
$24.55

Volume: 871,674 shs
Average Volume: 2.53 million shs
Market Capitalization: $90.13 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $13.67

Get Veru News Delivered to You Automatically

VERU Media Mentions By Week

VERU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VERU
News Sentiment
▼
0.00

0.66
▲
Average
Medical
News Sentiment

VERU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VERU Articles
This Week
▼
0

5
▲
VERU Articles
Average Week

Source

Source	Headline
	Veru Announces Appointment of Dr. Erik Swenson and Dr. Robert Schooley to its Infectious Disease Scientific Advisory Board finance.yahoo.com - June 1 at 9:53 AM
	Veru to Present at the Jefferies Healthcare Conference finance.yahoo.com - May 24 at 8:58 AM
	HC Wainwright Equities Analysts Decrease Earnings Estimates for Veru Inc. (NASDAQ:VERU) americanbankingnews.com - May 20 at 2:58 AM
	HC Wainwright & Co. Maintains Veru (VERU) Buy Recommendation msn.com - May 15 at 4:58 PM
	H.C. Wainwright Sticks to Its Buy Rating for Veru (VERU) markets.businessinsider.com - May 15 at 8:36 AM
	Veru (NASDAQ:VERU) PT Lowered to $2.00 americanbankingnews.com - May 15 at 7:56 AM
	Veru Inc.: Veru Reports Fiscal 2023 Second Quarter Financial Results finanznachrichten.de - May 12 at 8:49 PM
	Veru Q2: Revenue Halves, Prioritizes Clinical Programs, Wider Loss & More msn.com - May 12 at 10:49 AM
	Veru Inc. (VERU) Reports Q2 Loss, Tops Revenue Estimates finance.yahoo.com - May 11 at 1:35 PM
	Veru: Q2 Earnings Insights msn.com - May 11 at 8:34 AM
	VERU Stock Earnings: Veru Misses EPS, Beats Revenue Estimates markets.businessinsider.com - May 11 at 8:34 AM
	Veru Reports Fiscal 2023 Second Quarter Financial Results finance.yahoo.com - May 11 at 8:34 AM
	Analyst Ratings for Veru markets.businessinsider.com - May 10 at 3:55 PM
	A Preview Of Veru's Earnings msn.com - May 10 at 3:55 PM
	Veru Q2 2023 Earnings Preview msn.com - May 10 at 3:55 PM
	Is a Surprise Coming for Veru (VERU) This Earnings Season? finance.yahoo.com - May 9 at 3:10 PM
	Veru (VERU) Set to Announce Quarterly Earnings on Thursday americanbankingnews.com - May 9 at 4:34 AM
	Veru Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin Treatment of Hospitalized COVID-19 Adult Patients at High Risk for ARDS finance.yahoo.com - May 4 at 1:26 PM
	Veru Inc. (VERU) Expected to Beat Earnings Estimates: Can the Stock Move Higher? finance.yahoo.com - May 4 at 1:26 PM
	Veru (VERU) to Release Quarterly Earnings on Thursday marketbeat.com - May 4 at 2:25 AM
	Veru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capital finance.yahoo.com - May 3 at 10:58 AM
	Q2 2023 Earnings Estimate for Veru Inc. (NASDAQ:VERU) Issued By HC Wainwright americanbankingnews.com - April 30 at 1:44 AM
	Veru Inc. (NASDAQ:VERU) Receives Consensus Rating of "Buy" from Analysts americanbankingnews.com - April 29 at 5:08 AM
	Veru Inc. (NASDAQ:VERU) Short Interest Update marketbeat.com - April 28 at 9:50 AM
	Q2 2023 EPS Estimates for Veru Inc. Reduced by HC Wainwright (NASDAQ:VERU) marketbeat.com - April 28 at 6:40 AM
	Veru to Report Fiscal 2023 Second Quarter Financial Results on May 11, 2023 finance.yahoo.com - April 27 at 9:44 AM
	Veru Sells ENTADFI® Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones finance.yahoo.com - April 20 at 9:08 AM
	Veru Enters Into Supply Agreement with Afaxys to Expand Access to FC2 Female Condom® in U.S. Public Health Sector finance.yahoo.com - April 19 at 1:28 PM
	Veru (NASDAQ:VERU) Receives Buy Rating from HC Wainwright americanbankingnews.com - April 15 at 3:16 AM
	The Latest Analyst Ratings for Veru markets.businessinsider.com - April 13 at 4:38 PM
	HC Wainwright & Co. Reiterates Veru (VERU) Buy Recommendation msn.com - April 13 at 4:38 PM
	Down -51.21% in 4 Weeks, Here's Why You Should You Buy the Dip in Veru Inc. (VERU) finance.yahoo.com - April 12 at 1:37 PM
	Once COVID-19 Candidate, Veru's Sabizabulin Shows Encouraging Action In Animal Studies Against Poxvirus finance.yahoo.com - April 11 at 8:32 PM
	Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses finance.yahoo.com - April 11 at 10:31 AM
	Veru (NASDAQ:VERU) Given New $6.00 Price Target at HC Wainwright americanbankingnews.com - April 7 at 7:28 AM
	Veru Inc. (NASDAQ:VERU) Receives $28.33 Average Target Price from Analysts americanbankingnews.com - April 7 at 3:30 AM
	Veru Announces Preclinical Results from Expanded Sabizabulin Program into Influenza-Induced Severe Acute Respiratory Distress Syndrome and Provides Update on COVID-19 Program finance.yahoo.com - April 4 at 1:31 PM
	Veru Inc.'s (NASDAQ:VERU) recent 20% pullback adds to one-year year losses, institutional owners may take drastic measures finance.yahoo.com - March 27 at 8:25 AM
	Oppenheimer Weighs in on Veru Inc.'s Q2 2023 Earnings (NASDAQ:VERU) marketbeat.com - March 17 at 6:20 AM
	UPDATE 1-Veru to proceed with late-stage study of COVID pill despite FDA snub finance.yahoo.com - March 14 at 5:52 PM
	407,139 Shares in Veru Inc. (NASDAQ:VERU) Acquired by Renaissance Technologies LLC marketbeat.com - March 13 at 4:35 AM
	Veru Inc. (NASDAQ:VERU) Given Consensus Recommendation of "Buy" by Brokerages marketbeat.com - March 10 at 4:43 AM
	Veru to Present at the Oppenheimer 33rd Annual Healthcare Conference finance.yahoo.com - March 7 at 9:18 AM
	Why Is Veru (VERU) Stock Down 37% Today? investorplace.com - March 3 at 11:00 AM
	Veru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS finance.yahoo.com - March 2 at 6:59 PM
	Veru Inc. (NASDAQ:VERU) Shares Could Be 50% Below Their Intrinsic Value Estimate finance.yahoo.com - February 14 at 10:09 AM
	Veru Inc. (NASDAQ:VERU) Expected to Post Q1 2024 Earnings of ($0.13) Per Share marketbeat.com - February 13 at 3:06 AM
	Veru Inc. (NASDAQ:VERU) Q1 2023 Earnings Call Transcript finance.yahoo.com - February 10 at 8:09 PM
	Veru (NASDAQ:VERU) Price Target Cut to $14.00 by Analysts at HC Wainwright marketbeat.com - February 10 at 8:38 AM
	Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Veru Inc. (VERU) Investors of Class Action and to Actively Participate benzinga.com - February 7 at 4:38 AM

Get Veru News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:VERU) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Veru (VERU) News Today

VERU Media Mentions By Week

VERU Media Sentiment

VERU News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info